# Hyperpolarized 129Xe MRI of Survivors of COVID-19

> **NCT04659707** · PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 42 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Hyperpolarized Xe129

## Key facts

- **NCT ID:** NCT04659707
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-22
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04659707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04659707, "Hyperpolarized 129Xe MRI of Survivors of COVID-19". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04659707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*